Chemical Structure (Orkambi 01)
Orkambi Granule
Product Images NDC 51167-122
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Orkambi (NDC 51167-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vertex Pharmaceuticals Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Orkambi 02)
Figure (Orkambi 03)
Figure (Orkambi 04)
Principal Display Panel (200mg/125mg Tablet Box)
ORKAMBI® is a medication in the form of tablets containing a combination of lumacaftor and ivacaftor. It comes in a pack of 112 tablets, each containing 200mg of lumacaftor and 125mg of ivacaftor. The product code is NDG 5116730801.*
Principal Display Panel (100 mg/125 mg Tablet Box)
Orkambi 07
Orkambi 08
This seems to be a product description of a drug called ORKAMBI that is used for treating cystic fibrosis. It comes in a packet of oral granules with a dose of 150 mg/188 mg per packet. The text provides information on when to take ORKAMBI, specifically 12 hours later, and advises users to refer to the patient package insert for usage directions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
